The agreement, announced on Wednesday, was far lower than some analyst estimates, including JP Morgan's projection of $3.5 ...

Pfizer's ex-chair and chief executive Ian Read and Frank D'Amelio – previously the drugmaker's finance chief – have issued a ...

US economic optimism last night helped the S&P 500 index to set its 44th record high this year, having improved by another ...

Stocks seen off the mark Futures had the FTSE 100 dipping by 13 points on Thursday morning as London looked set for another ...

Shares of GSK are seen rising 5% according to pre-market indications on Thursday after the British drugmaker agreed to pay up ...

The concerns surrounding Zantac also prompted UK health authorities to advise doctors in 2019 to cease prescribing specific formulations of the drug as a precautionary measure. Reports indicated that ...

The Financial Times top stories cover HSBC's targeted cost-cutting strategy focusing on senior bankers, the UK government's ...

The recent better-than-expected U.S. nonfarm payrolls data has many market participants on edge for a hotter-than-anticipated inflation reading, said Matt Simpson, market analyst at FOREX.com and City ...

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over ...

GSK plc (GSK, GSK.L) announced that it has reached agreements with 10 plaintiff firms representing approximately 93% (around 80,000) ...

The deal settles 80,000 US court cases related to allegations that Zantac was contaminated with a suspected carcinogen.